(Q42140417)

17 October 2017

An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions (English)

1 reference

17 October 2017

1 reference

Hai-Liang Zhang

1

1 reference

17 October 2017

Xiao-Jian Qin

2

1 reference

17 October 2017

Da-Long Cao

3

1 reference

17 October 2017

Yao Zhu

4

1 reference

17 October 2017

Xu-Dong Yao

5

1 reference

17 October 2017

Shi-Lin Zhang

6

1 reference

17 October 2017

Bo Dai

7

1 reference

17 October 2017

Ding-Wei Ye

8

1 reference

17 October 2017

4 February 2013

1 reference

Asian Journal of Andrology

17 October 2017

1 reference

17 October 2017

15

1 reference

17 October 2017

2

1 reference

17 October 2017

231-235

1 reference

Changes in circulating microRNA levels associated with prostate cancer

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

29 May 2018

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

29 May 2018

miRNAs in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

A comparative study of prostate cancer detection and management in China and in France.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

MicroRNA in cancer prognosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Molecular markers in prostate cancer. Part II: potential roles in management

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Molecular mechanisms of metastasis in prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Serum microRNAs are promising novel biomarkers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Circulating microRNAs as stable blood-based markers for cancer detection

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Management of prostate cancer in China: a multicenter report of 6 institutions

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Isolation of cell-free RNA from maternal plasma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739140

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy

17 August 2018

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: comparison with the extent of disease (EOD) grade

1 reference

12 December 2020

The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone

1 reference

12 December 2020

Circulating miRNAs are correlated with tumor progression in prostate cancer

1 reference

12 December 2020

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJA.2012.116

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

23377530

1 reference